Pfizer
PFE
PFE
2,318 hedge funds and large institutions have $142B invested in Pfizer in 2019 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 986 increasing their positions, 1,010 reducing their positions, and 137 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,318
Holders Change
-56
Holders Change %
-2.36%
% of All Funds
50.91%
Holding in Top 10
81
Holding in Top 10 Change
-118
Holding in Top 10 Change %
-59.3%
% of All Funds
1.78%
New
99
Increased
986
Reduced
1,010
Closed
137
Calls
$1.16B
Puts
$1.43B
Net Calls
-$269M
Net Calls Change
-$661M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$2.14B |
| 2 |
JPMorgan Chase & Co
New York
|
$3.23B |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
$894M |
| 4 |
Wells Fargo
San Francisco,
California
|
$960M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
$95.7M |
